Loading...
Treatment Combinations with DNA Vaccines for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC)
SIMPLE SUMMARY: The only vaccine approved by FDA as a treatment for cancer is sipuleucel-T, a therapy for patients with metastatic castration-resistant prostate cancer (mCRPC). Most investigators studying anti-tumor vaccines believe they will be most effective as parts of combination therapies, rath...
Na minha lista:
| Udgivet i: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7601088/ https://ncbi.nlm.nih.gov/pubmed/33008010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12102831 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|